Mechanisms involved in cellular ceramide homeostasis
<p>Abstract</p> <p>Sphingolipids are ubiquitous and critical components of biological membranes. Their biosynthesis starts with soluble precursors in the endoplasmic reticulum and culminates in the Golgi complex and plasma membrane. Ceramides are important intermediates in the bios...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-07-01
|
| Series: | Nutrition & Metabolism |
| Subjects: | |
| Online Access: | http://www.nutritionandmetabolism.com/content/9/1/71 |
| _version_ | 1818569606320619520 |
|---|---|
| author | Hussain M Jin Weijun Jiang Xian-Cheng |
| author_facet | Hussain M Jin Weijun Jiang Xian-Cheng |
| author_sort | Hussain M |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Sphingolipids are ubiquitous and critical components of biological membranes. Their biosynthesis starts with soluble precursors in the endoplasmic reticulum and culminates in the Golgi complex and plasma membrane. Ceramides are important intermediates in the biosynthesis of sphingolipids, such as sphingomyelin, and their overload in the membranes is injurious to cells. The major product of ceramide metabolism is sphingomyelin. We observed that sphingomyelin synthase (SMS) 1 or SMS2 deficiencies significantly decreased plasma and liver sphingomyelin levels. However, SMS2 but not SMS1 deficiency increased plasma ceramides. Surprisingly, SMS1 deficiency significantly increased glucosylceramide and ganglioside GM3, but SMS2 deficiency did not. To explain these unexpected findings about modest to no significant changes in ceramides and increases in other sphingolipids after the ablation of SMS1, we hypothesize that cells have evolved several organelle specific mechanisms to maintain ceramide homeostasis. First, ceramides in the endoplasmic reticulum membranes are controlled by its export to Golgi by protein mediated transfer. Second, in the Golgi, ceramide levels are modulated by their enzymatic conversion to different sphingolipids such as sphingomyelin, and glucosylceramides. Additionally, these sphingolipids can become part of triglyceride-rich apolipoprotein B-containing lipoproteins and be secreted. Third, in the plasma membrane ceramide levels are maintained by ceramide/sphingomyelin cycle, delivery to lysosomes, and efflux to extracellular plasma acceptors. All these pathways might have evolved to ensure steady cellular ceramide levels.</p> |
| first_indexed | 2024-12-14T06:50:08Z |
| format | Article |
| id | doaj.art-f107ec1b28894918a354abb5a690bb8b |
| institution | Directory Open Access Journal |
| issn | 1743-7075 |
| language | English |
| last_indexed | 2024-12-14T06:50:08Z |
| publishDate | 2012-07-01 |
| publisher | BMC |
| record_format | Article |
| series | Nutrition & Metabolism |
| spelling | doaj.art-f107ec1b28894918a354abb5a690bb8b2022-12-21T23:12:55ZengBMCNutrition & Metabolism1743-70752012-07-01917110.1186/1743-7075-9-71Mechanisms involved in cellular ceramide homeostasisHussain MJin WeijunJiang Xian-Cheng<p>Abstract</p> <p>Sphingolipids are ubiquitous and critical components of biological membranes. Their biosynthesis starts with soluble precursors in the endoplasmic reticulum and culminates in the Golgi complex and plasma membrane. Ceramides are important intermediates in the biosynthesis of sphingolipids, such as sphingomyelin, and their overload in the membranes is injurious to cells. The major product of ceramide metabolism is sphingomyelin. We observed that sphingomyelin synthase (SMS) 1 or SMS2 deficiencies significantly decreased plasma and liver sphingomyelin levels. However, SMS2 but not SMS1 deficiency increased plasma ceramides. Surprisingly, SMS1 deficiency significantly increased glucosylceramide and ganglioside GM3, but SMS2 deficiency did not. To explain these unexpected findings about modest to no significant changes in ceramides and increases in other sphingolipids after the ablation of SMS1, we hypothesize that cells have evolved several organelle specific mechanisms to maintain ceramide homeostasis. First, ceramides in the endoplasmic reticulum membranes are controlled by its export to Golgi by protein mediated transfer. Second, in the Golgi, ceramide levels are modulated by their enzymatic conversion to different sphingolipids such as sphingomyelin, and glucosylceramides. Additionally, these sphingolipids can become part of triglyceride-rich apolipoprotein B-containing lipoproteins and be secreted. Third, in the plasma membrane ceramide levels are maintained by ceramide/sphingomyelin cycle, delivery to lysosomes, and efflux to extracellular plasma acceptors. All these pathways might have evolved to ensure steady cellular ceramide levels.</p>http://www.nutritionandmetabolism.com/content/9/1/71SphingomyelinCeramidesGangliosidesLipoproteinsEndoplasmic reticulumGolgiPlasma membrane |
| spellingShingle | Hussain M Jin Weijun Jiang Xian-Cheng Mechanisms involved in cellular ceramide homeostasis Nutrition & Metabolism Sphingomyelin Ceramides Gangliosides Lipoproteins Endoplasmic reticulum Golgi Plasma membrane |
| title | Mechanisms involved in cellular ceramide homeostasis |
| title_full | Mechanisms involved in cellular ceramide homeostasis |
| title_fullStr | Mechanisms involved in cellular ceramide homeostasis |
| title_full_unstemmed | Mechanisms involved in cellular ceramide homeostasis |
| title_short | Mechanisms involved in cellular ceramide homeostasis |
| title_sort | mechanisms involved in cellular ceramide homeostasis |
| topic | Sphingomyelin Ceramides Gangliosides Lipoproteins Endoplasmic reticulum Golgi Plasma membrane |
| url | http://www.nutritionandmetabolism.com/content/9/1/71 |
| work_keys_str_mv | AT hussainm mechanismsinvolvedincellularceramidehomeostasis AT jinweijun mechanismsinvolvedincellularceramidehomeostasis AT jiangxiancheng mechanismsinvolvedincellularceramidehomeostasis |